Exchange Traded Concepts, LLC Immuno Gen, Inc. Transaction History

Exchange Traded Concepts, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 05, 2024	BUY	$12.46 - $29.95 $28,172 - $67,716	2,261 Added 33.96%	8,918 $264,000
Q3 2023 Oct 18, 2023	SELL	$14.09 - $19.87 $18,147 - $25,592	-1,288 Reduced 16.21%	6,657 $105,000
Q2 2023 Jul 20, 2023	BUY	$3.75 - $20.05 $29,793 - $159,297	7,945 New	7,945 $149,000

1.41M

Ticker IMGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 220,712,992
Description
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...

Get notified when there are updates to the investment portfolio of Exchange Traded Concepts, LLC, based on Form 13F filings with the SEC.

Stay updated on Exchange Traded Concepts, LLC with notifications on news.